255 related articles for article (PubMed ID: 16777224)
21. A rare case report of 8p11 myeloid and lymphoid neoplasm with FGFR1 abnormality in a young adult.
Shaaban H; Dabu J; Al-Rabi K; Gauchan D; Guron G
Ann Hematol; 2013 Jan; 92(2):285-6. PubMed ID: 22941307
[No Abstract] [Full Text] [Related]
22. Identification of a novel partner gene, TPR, fused to FGFR1 in 8p11 myeloproliferative syndrome.
Li F; Zhai YP; Tang YM; Wang LP; Wan PJ
Genes Chromosomes Cancer; 2012 Sep; 51(9):890-7. PubMed ID: 22619110
[TBL] [Abstract][Full Text] [Related]
23. A further case of myeloproliferative syndrome with reciprocal translocation (8;13)(p11;q12).
Invernizzi R; Benatti C; Travaglino E; Girino M; Bernasconi P; Loni C; Ascari E
Haematologica; 2004 Feb; 89(2):239-41. PubMed ID: 15003903
[No Abstract] [Full Text] [Related]
24. Myeloproliferative neoplasms with t(8;22)(p11.2;q11.2)/BCR-FGFR1: a meta-analysis of 20 cases shows cytogenetic progression with B-lymphoid blast phase.
Montenegro-Garreaud X; Miranda RN; Reynolds A; Tang G; Wang SA; Yabe M; Wang W; Fang L; Bueso-Ramos CE; Lin P; Medeiros LJ; Lu X
Hum Pathol; 2017 Jul; 65():147-156. PubMed ID: 28551329
[TBL] [Abstract][Full Text] [Related]
25. Chromosome 8p11.2 translocations: prevalence, FISH analysis for FGFR1 and MYST3, and clinicopathologic correlates in a consecutive cohort of 13 cases from a single institution.
Patnaik MM; Gangat N; Knudson RA; Keefe JG; Hanson CA; Pardanani A; Ketterling RP; Tefferi A
Am J Hematol; 2010 Apr; 85(4):238-42. PubMed ID: 20143402
[TBL] [Abstract][Full Text] [Related]
26. The genomic structure of ZNF198 and location of breakpoints in the t(8;13) myeloproliferative syndrome.
Kulkarni S; Reiter A; Smedley D; Goldman JM; Cross NC
Genomics; 1999 Jan; 55(1):118-21. PubMed ID: 9889006
[TBL] [Abstract][Full Text] [Related]
27. t(6;8), t(8;9) and t(8;13) translocations associated with stem cell myeloproliferative disorders have close or identical breakpoints in chromosome region 8p11-12.
Chaffanet M; Popovici C; Leroux D; Jacrot M; Adélaïde J; Dastugue N; Grégoire MJ; Hagemeijer A; Lafage-Pochitaloff M; Birnbaum D; Pébusque MJ
Oncogene; 1998 Feb; 16(7):945-9. PubMed ID: 9484786
[TBL] [Abstract][Full Text] [Related]
28. 8p11 myeloproliferative syndrome preceded by t(8;9)(p11;q33), CEP110/FGFR1 fusion transcript: morphologic, molecular, and cytogenetic characterization of myeloid neoplasms associated with eosinophilia and FGFR1 abnormality.
Park TS; Song J; Kim JS; Yang WI; Song S; Kim SJ; Suh B; Choi JR
Cancer Genet Cytogenet; 2008 Mar; 181(2):93-9. PubMed ID: 18295660
[TBL] [Abstract][Full Text] [Related]
29. Myeloid and lymphoid neoplasm with FGFR1 abnormality.
Keane C; Henden A; Mills T; Wood P
Br J Haematol; 2009 May; 145(4):440. PubMed ID: 19076174
[No Abstract] [Full Text] [Related]
30. Precursor T-Lymphoblastic Lymphoma Associated with t(8;9)(p11.2;q33): A Case Report and Review of the Literature.
Lv H; Hu S; Lu J; Zhai Q; Zhai Z; Du Z; Sun Y; Li J; He H; Wang Y
Acta Haematol; 2018; 139(3):176-182. PubMed ID: 29614500
[TBL] [Abstract][Full Text] [Related]
31. 8p11 myeloproliferative syndrome with t(1;8)(q25;p11.2): a case report and review of the literature.
Kim WS; Park SG; Park G; Jang SJ; Moon DS; Kang SH
Acta Haematol; 2015; 133(1):101-5. PubMed ID: 25227135
[TBL] [Abstract][Full Text] [Related]
32. A case of chronic myeloproliferative syndrome followed by precursor T-cell acute lymphoblastic leukemia.
Bacher U; Haferlach T; Kern W; Harich HD; Schnittger S; Haferlach C
Cancer Genet Cytogenet; 2007 May; 175(1):52-6. PubMed ID: 17498558
[TBL] [Abstract][Full Text] [Related]
33. 14-3-3 Integrates prosurvival signals mediated by the AKT and MAPK pathways in ZNF198-FGFR1-transformed hematopoietic cells.
Dong S; Kang S; Gu TL; Kardar S; Fu H; Lonial S; Khoury HJ; Khuri F; Chen J
Blood; 2007 Jul; 110(1):360-9. PubMed ID: 17389761
[TBL] [Abstract][Full Text] [Related]
34. 8p11 myeloproliferative syndrome: diagnostic challenges and pitfalls.
Antic DA; Vukovic VM; Milosevic Feenstra JD; Kralovics R; Bogdanovic AD; Dencic Fekete MS; Mihaljevic BS
J BUON; 2016; 21(3):745-9. PubMed ID: 27569099
[TBL] [Abstract][Full Text] [Related]
35. Chronic myeloproliferative disorder with t(8;22)(p11;q11) can mime clonal cytogenetic evolution of authentic chronic myelogeneous leukemia.
Richebourg S; Theisen O; Plantier I; Parry A; Soenen-Cornu V; Lepelley P; Preudhomme C; Renneville A; Laï JL; Roche-Lestienne C
Genes Chromosomes Cancer; 2008 Oct; 47(10):915-8. PubMed ID: 18615682
[No Abstract] [Full Text] [Related]
36. Cytogenetic and molecular aspects of Philadelphia negative chronic myeloproliferative disorders: clinical implications.
Panani AD
Cancer Lett; 2007 Sep; 255(1):12-25. PubMed ID: 17383090
[TBL] [Abstract][Full Text] [Related]
37. Hematologic malignancies with PCM1-JAK2 gene fusion share characteristics with myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB, and FGFR1.
Patterer V; Schnittger S; Kern W; Haferlach T; Haferlach C
Ann Hematol; 2013 Jun; 92(6):759-69. PubMed ID: 23400675
[TBL] [Abstract][Full Text] [Related]
38. Dual lympho-myeloproliferative disorder in a patient with t(8;22) with BCR-FGFR1 gene fusion.
Murati A; Arnoulet C; Lafage-Pochitaloff M; Adélaide J; Derré M; Slama B; Delaval B; Popovici C; Vey N; Xerri L; Mozziconacci MJ; Boulat O; Sainty D; Birnbaum D; Chaffanet M
Int J Oncol; 2005 Jun; 26(6):1485-92. PubMed ID: 15870860
[TBL] [Abstract][Full Text] [Related]
39. Translocation t(8;13) in a patient with T cell lymphoma and features of a myeloproliferative syndrome.
Behringer D; Schaefer HE; Kunzmann R; Mertelsmann R; Dölken G
Leukemia; 1995 Jun; 9(6):988-92. PubMed ID: 7596190
[TBL] [Abstract][Full Text] [Related]
40. Consistent fusion of ZNF198 to the fibroblast growth factor receptor-1 in the t(8;13)(p11;q12) myeloproliferative syndrome.
Reiter A; Sohal J; Kulkarni S; Chase A; Macdonald DH; Aguiar RC; Gonçalves C; Hernandez JM; Jennings BA; Goldman JM; Cross NC
Blood; 1998 Sep; 92(5):1735-42. PubMed ID: 9716603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
